logo-loader
AIM:EKF

EKF Diagnostics

Receive alerts
Market:
AIM
Price
23.90 GBX
Day Change
2.14%
Market Cap:
£102.28 m
52 weeks high
29.00
52 weeks low
21.80

In brief

 
Our range of blood analysers are simple to use and designed to quickly deliver accurate results to aid the diagnosis of anemia, diabetes and associated conditions.
 
EKF analyzers are used in more than 70 countries by healthcare professionals in blood banks, GP surgeries, diabetes clinics, pharmacies, hospitals, sports medicine and laboratories.
 

Latest news

RNS

Share Buyback

on 09/29/2026
RNS

Share Buyback

on 09/28/2026
RNS

Interim Results

on 09/15/2026
RNS

Share Buyback

on 09/03/2026
RNS

Share Buyback

on 09/01/2026
RNS

Share Buyback

on 08/28/2026